Tony Huge

7,8-Dihydroxyflavone: The Oral BDNF Mimetic That Rewires the Brain

TL;DR 7,8-DHF is a small-molecule TrkB agonist — the first compound to mimic BDNF (Brain-Derived Neurotrophic Factor) and cross the blood-brain barrier orally. Mechanism: Direct binding and activation of TrkB receptors, triggering the same downstream signaling cascade as endogenous BDNF — CREB, Akt, and MAPK phosphorylation. Who it’s for: Anyone wanting neuroprotection, enhanced learning, treatment-resistant […]

Solriamfetol: Overpriced, Hard to Get, and Underwhelming — Why FL-Modafinil Wins

TL;DR Solriamfetol (Sunosi) is a dopamine-norepinephrine reuptake inhibitor (DNRI) FDA-approved for excessive daytime sleepiness in narcolepsy and obstructive sleep apnea. Binding affinity is weak: Ki of 14.2 µM at DAT and 3.7 µM at NET — three to four orders of magnitude weaker than classic stimulants. It is brutally expensive: ~$1,230 per 30 tablets at […]

Better Than Natural: Nootropics Field Report — April 2026

The complete quarterly field report on cognitive enhancement — clinical research updates, underground intelligence, Tony Huge’s personal protocol, compound hierarchy rankings, and goal-specific stacks. Frontier data meets clinical evidence. Edition #001.